Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.3x

Market Cap

CNY 5.46B

MomentumView details →

1D Return

−5.62%

YTD Return

−26.17%

RSI (14)

46.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.3x

Market Cap

CNY 5.46B

RSI (14)

46.3

MomentumView details →

1D Return

−5.62%

YTD Return

−26.17%

ProfitabilityView details →

Gross Margin

71.59%

Net Margin

13.41%

EBITDA Margin

22.05%

ROE (TTM)

14.99%

ROA (TTM)

9.80%

Asset Turnover

0.74x

GrowthView details →

Revenue YoY

−0.85%

EPS YoY

−22.64%

FCF YoY

—

Revenue CAGR 3Y

+10.17%

EPS CAGR 3Y

+5.39%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

3.73x

Quick Ratio

2.81x

Div Yield

3.62%

Div Rate

CNY 0.40

Div Growth 1Y

+27.81%

Financials snapshotView financials →

Revenue (TTM)

3.01B

Net Income (TTM)

403.78M

Op. CF (TTM)

577.63M

Latest newsMore news →

Jiudian Pharmaceutical participated in the bidding for the 12th batch of national centralized drug procurement on July 31, 2026, and its two products, ferrous succinate tablets and indobufen tablets, are provisionally selected, with nationwide supply.34d ago

Similar companies

兄弟科技002562.SZ 丰元股份002805.SZ 金财互联002530.SZ ST晨鸣000488.SZ 新北洋002376.SZ 通合科技300491.SZ Find similar companies →

Latest newsMore news →

Jiudian Pharmaceutical participated in the bidding for the 12th batch of national centralized drug procurement on July 31, 2026, and its two products, ferrous succinate tablets and indobufen tablets, are provisionally selected, with nationwide supply.34d ago